The LAM Cell Atlas confirmed that TLR9 expressing pDCs are present in human LAM lung tissues, suggesting that a TLR9 stimulating treatment could be successfully translated to humans. This evidence concerns the gene TLR9 and lymphangioleiomyomatosis.